CARMELLINI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 11.669
EU - Europa 10.196
AS - Asia 6.332
SA - Sud America 1.092
AF - Africa 236
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 9
Totale 29.568
Nazione #
US - Stati Uniti d'America 11.527
CN - Cina 2.548
GB - Regno Unito 2.465
SG - Singapore 1.927
RU - Federazione Russa 1.724
IE - Irlanda 1.489
UA - Ucraina 1.147
BR - Brasile 922
FR - Francia 795
SE - Svezia 774
IT - Italia 710
DE - Germania 553
HK - Hong Kong 479
VN - Vietnam 436
KR - Corea 384
FI - Finlandia 313
ZA - Sudafrica 146
IN - India 141
BD - Bangladesh 82
CA - Canada 75
ES - Italia 72
AR - Argentina 63
TR - Turchia 50
IQ - Iraq 47
JP - Giappone 40
MX - Messico 39
AU - Australia 27
BE - Belgio 26
NG - Nigeria 25
PK - Pakistan 23
PL - Polonia 20
VE - Venezuela 20
EC - Ecuador 19
UZ - Uzbekistan 19
CO - Colombia 18
KE - Kenya 16
ID - Indonesia 15
MY - Malesia 15
CL - Cile 14
PY - Paraguay 13
RO - Romania 13
NL - Olanda 11
SA - Arabia Saudita 11
AT - Austria 10
JO - Giordania 10
PE - Perù 10
PH - Filippine 10
EU - Europa 9
IL - Israele 9
MA - Marocco 9
NP - Nepal 9
CI - Costa d'Avorio 8
CZ - Repubblica Ceca 8
IR - Iran 8
KZ - Kazakistan 8
OM - Oman 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
EG - Egitto 7
HU - Ungheria 7
JM - Giamaica 7
KG - Kirghizistan 7
AZ - Azerbaigian 6
LT - Lituania 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
UY - Uruguay 6
AL - Albania 5
CH - Svizzera 5
DZ - Algeria 5
EE - Estonia 5
GR - Grecia 5
LB - Libano 5
BG - Bulgaria 4
BH - Bahrain 4
DK - Danimarca 4
KW - Kuwait 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
MD - Moldavia 3
NI - Nicaragua 3
PA - Panama 3
SN - Senegal 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
BW - Botswana 2
CR - Costa Rica 2
HN - Honduras 2
HR - Croazia 2
ME - Montenegro 2
MK - Macedonia 2
PT - Portogallo 2
TW - Taiwan 2
BJ - Benin 1
CY - Cipro 1
DM - Dominica 1
Totale 29.547
Città #
Southend 2.231
Dublin 1.486
Dallas 1.321
Fairfield 1.122
Singapore 979
Chandler 924
Jacksonville 905
Ashburn 723
Hefei 533
Woodbridge 512
Wilmington 483
Beijing 463
Hong Kong 459
Santa Clara 455
Moscow 425
Seoul 379
Seattle 368
Cambridge 361
Houston 352
Nanjing 347
Ann Arbor 327
The Dalles 283
Princeton 265
San Jose 221
Boardman 174
Lauterbourg 164
Los Angeles 149
Ho Chi Minh City 144
Siena 136
Johannesburg 125
New York 121
Buffalo 110
Nanchang 107
Helsinki 104
Dearborn 91
San Diego 91
Hanoi 87
São Paulo 68
Milan 56
Shenyang 55
Shanghai 54
Tianjin 54
Hebei 51
Bengaluru 50
Council Bluffs 49
Madrid 49
Kunming 46
Rome 46
Munich 41
Jiaxing 39
San Francisco 39
Orem 38
Jinan 37
Tokyo 37
Changsha 36
Toronto 36
Rio de Janeiro 35
London 32
Philadelphia 31
Dong Ket 30
Hangzhou 30
Menlo Park 30
Zhengzhou 26
Brasília 25
Brussels 25
Columbus 24
San Mateo 23
Belo Horizonte 21
Chennai 21
Da Nang 21
Guangzhou 21
Haiphong 21
Chicago 20
Dhaka 20
Norwalk 20
Abuja 19
Changchun 19
Lancaster 18
Nuremberg 18
Turku 18
Frankfurt am Main 17
Redondo Beach 17
Venezia 17
Ningbo 16
Stockholm 16
Sydney 16
Tashkent 16
Baghdad 15
Manchester 15
Montreal 15
Atlanta 14
Auburn Hills 14
Düsseldorf 14
Iesi 14
Kuala Lumpur 14
Lanzhou 14
Taizhou 14
Mexico City 13
Naples 13
Brooklyn 12
Totale 19.272
Nome #
ANDAMENTO LONGITUDINALE DI BIOMARKERS DI INFIAMMAZIONE ED IMMUNOATTIVAZIONE IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI RENE: UN RUOLO DELLA REPLICAZIONE DI CMV? 346
Analysis of the IgVH genes in T cell-mediated and antibody-mediated rejection of the kidney graft. 323
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early [vs. delayed] introduction of everolimus in de novo kidney transplant recipients, with a follow-up evaluation at 12 month after transplant (NEVERWOUND study) 299
L'accesso chirurgico all'arteria femorale comune: considerazioni anatomiche in relazione alla profilassi dell'infezione delle protesi arteriose 288
HCMV infection in renal transplant recipients: a retrospective cohort study 280
Renal infarction due to polyarteritis nodosa in a patient with angioimmunoblastic T-cell lymphoma: a case report and a brief review of the literature 279
Monitoring kidney-transplant patients using metabolomics and dynamic modeling 276
Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy [Sieroprevalenza dell’infezione da virus dell’epatite E (HEV) in donatori di sangue e pazienti trapiantati di rene: Uno studio retrospettivo dal centro Italia] 265
A randomized study comparing three cyclosporine based regimens in cadaveric renal transplantation: results at 7 years 263
Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients. 262
Sieroprevalenza di HEV in donatori di sangue e pazienti trapiantati di rene nella provincia di Siena. 260
Using metabolomics to monitor kidney transplantation patients by means of clustering to spot anomalous patient behavior 260
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 256
Bilateral renal cell carcinoma of the native kidneys after renal transplantation 251
Cardiac arrest following intravenous administration of Clindamycin phosphate [Arresto cardiaco indotto dalla somministrazione endovenosa di clindamicina fosfato. Descrizione di un caso clinico] 241
SIEROPREVALENZA DI HEV IN UNA COORTE DI PAZIENTI CANDIDATI A TRAPIANTO RENALE 241
Conversion of stable kidney transplant recipients from a twice-daily to once-daily everolimus regimen. 238
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 232
Establishment and characterization of murine small cell lung carcinoma cell lines derived from HPV-16 E6/E7 transgenic mice. 224
Cytomegalovirus infection with multiple colonic perforations in a renal transplant recipient 222
A randomized study comparing Cyclosporine alone vs double and triple therapy in renal transplants 217
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids? 217
Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients 216
Acute Ciclosporin Nephrotoxicity in Renal Transplant Patients 215
Immediate Introduction of Everolimus Does Not Affect Wound Healing and Delayed Graft Function in Renal Transplant Patients: Preliminary Results From NEVERWOUND Study 213
ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus 212
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation 210
A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine 207
Massive hemothorax after removal of subclavian vein catheter: a very unusual complication 205
Calcineurin-inhibitor induced pain syndrome after organ transplantation. 202
A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine 200
99mTc-DTPA scintigraphy in renal allograft rejection 197
A Randomized Study Comparing Three Cyclosporine-Based Regimens in Cadaveric Renal Transplantation 194
Acute Changes in Serum CEA Induced by Surgery in Colorectal Cancer Patients 189
Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine 189
A study of pig kidneys to expand organ pool 183
Standardized psychological evaluation pre and post transplantation: a new option 182
Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy 182
Transplantation of bovine pancreatic islets into the thymus of nonimmunosuppressed pigs 181
Tacrolimus is highly effective in both dual and triple therapy regimens following renal transplantation 180
Efficacy of everolimus with reduced-exposure cyclosporine in de novo kidney transplant patients at increased risk for efficacy events: analysis of a randomized trial 180
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey 180
Imipenem/Cilastatin reduces cyclosporin-induced tubular damage in kidney transplant recipients 178
Confronto tra duplice e triplice terapia immunosoppressiva nel trapianto di rene da cadavere. Studio retrospettivo 177
Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome 177
Pancreatic glucagon damages isolated human islet function 175
Hepatocyte grafting as an alternative to liver transplant 174
Mycophenolate Mofetil/Neoral/Steroid vs Neoral/Steroid therapy for prophylaxis of acute rejection in renal transplant recipients 173
Long-term outcome of renal transplantation from marginal donors 172
Kidney transplantation from donors aged 65 years or more as single or dual grafts 172
Renal transplant from very old donors: how far can we go? 171
Effect of kidney transplantation on quality of life measures 171
Laparoscopic nephrectomy for massive kidneys in polycystic kidney disease 171
Il ruolo dell'infezione da CMV e del suo monitoraggio attivo nella nuova era dei trapianti di rene: risultati di una coorte completa 170
Conversion of Stable Kidney Transplant Recipients from a Twice-Daily Everolimus Regimen to a Once-Daily Everolimus Regimen. 169
Xenotransplantation of bovine islets into the thymus of totally pancreatectomized pigs 168
Acute effects of peritoneousvenous shunt on the hemodynamics and gas exchange in patients with hepatic intractable ascites 168
Generalized lymphedema in a sirolimus-treated renal transplant patient 167
Role of Ultrasound in Renal Transplantation 166
Diagnosis and approach to posttransplant diabetes. 165
Effects of prolonged exposure to pancreatic glucagon on the function, antigenicity and survival of isolated human islets 164
Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results 164
Transplantation of purified bovine islets into the thymus of non-immunosuppressed pigs 162
Effects of glibenclamide and metformin (alone or in combination) on insulin release from isolated human pancreatic islets 162
Uso dell'emodiluizione normovolemica in chirurgia vascolare: prevenzione dell'edema e della trombosi venosa post-operatoria 162
Preparation and long-term culture of isolated human pancreatic islets 161
Activated coagulation time for the assessment of heparin-induced anticoagulation in peripheral vascular surgery [Il tempo di coagulazione attivato per la valutazione dell'anticoagulazione da eparina nella chirurgia vascolare periferica] 161
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study 161
Renal transplantation following reduction of ileocecocystoplasty performed 9 years earlier for undiversion 161
Effects of monensin on insulin release from isolated human islets 159
Causes and effects of delayed graft function in cadaveric renal transplantation: a multivariate analysis 158
Hepatocyte grafting as an alternative to liver transplant 157
safe conversion of stable kidney transplant recipients from twice-daily tacrolimus (Prograf) to once-daily modified release tacrolimus (advagraf) 156
Serum CEA monitoring in the follow up of colorectal cancer patients with negative preoperative serum CEA 156
Risk factors for cardiovascular disease in patients with functioning kidney grafts 155
Effect of immunosuppressive regimens on neutrophil chemotaxis 154
Fate of kidneys retrieved from the same donor and grafted into different recipients: do donor related factors influence the graft outcome? 154
An unusual complication of percutaneous catheterization of the internal jugular vein 153
Peripheral benzodiazepine receptors in isolated human pancreatic-islets 151
Proton magnetic resonance spectroscopy in renal transplant patients 151
Rejection in Liver Allograft Recipients: Clinical Characterization and Management 151
The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose 150
Regional vs. national renal sharing organizations: pros and cons 149
Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure. 149
Warren's operation in emergency:limits and indications. Value of the coronaro-spleno-renal decompression 148
Surgical endarterectomy for suprarenal iliac artery stenosis in renal allograft recipient 148
Utilizzazione di una associazione antibiotica e coagulante nella chirurgia della mammella 147
Bovine to porcine intrathymic islet xenotransplantation 146
Peripheral Benzodiazepine receptors in isolated human pancreatic islets 145
Urinary excretion rates of multiple renal indicators after kidney transplantation: clinical significance for early graft outcome 144
Long-Term Function of Kidneys From an Acute Renal Failure Donor on Continuous Venovenous Hemofiltration: A Case Report 143
A multicenter randomized open-label study to evaluate the effects of early Cyclosporine withdrawal versus reduction in de novo renal transplant patients receiving Sirolimus, Cyclosporine, Steroids and Basiliximab induction. Interim analysis at three months. 142
Exposure-Response Analysis of Everolimus with Reduced Cyclosporine in Renal Transplant Recipients at 24 Months in a Randomized Trial. 139
Excellent long term results in de-novo renal transplant recipients treated with m-TOR inhibitors, basiliximab and reduced calcineurin inhibitors exposure 139
Two corticosteroid-free regimens tacrolimus monotherpapy after basiliximab administration and tacrolimus/mycophenolatemofetil in comparison with a standard triple regimen in renal transplatation: results of the Atlas study 138
Explant of one graft due to technical complications in dual kidney transplants: analysis of the long-term function of the remaining kidney 138
Double-therapy vs Triple-therapy immunosuppression in cadaveric renal transplants 137
Tacrolimus-Based, Steroid-Free Regimens in Renal Transplantation: 3-Year Follow-up of the ATLAS Trial 135
Suramin as an Anticomplementary Agent in Xenotransplantation 134
Ruolo della terapia immunosoppressiva sulla funzione dei neutrofili 134
Totale 18.759
Categoria #
all - tutte 90.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021408 0 0 0 0 0 0 0 0 0 0 250 158
2021/20221.977 135 249 88 282 57 50 65 112 90 224 160 465
2022/20233.449 230 152 410 526 393 761 38 291 391 38 147 72
2023/20241.926 110 57 131 53 52 589 646 69 3 26 16 174
2024/20253.917 68 259 302 224 406 142 82 266 317 183 417 1.251
2025/20268.140 761 1.549 894 784 1.457 416 1.021 361 287 454 156 0
Totale 29.668